Stock TELO TELOMIR PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Telomir Pharmaceuticals, Inc.

Equities

TELO

US87975F1049

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
6.54 USD +10.29% Intraday chart for Telomir Pharmaceuticals, Inc. -4.39% 0.00%
Apr. 16 Telomir Pharmaceuticals, Inc. Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C CI
Apr. 12 Telomir Pharmaceuticals, Inc. Announces Resignation of Christos Nicholoudis, Esq. as the General Counsel and A Member of the Board of Directors CI

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.1381 -0.8541 -3.942
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.1381 -0.8541 -13.07
Net income 1 -0.1381 -0.8541 -13.07
Net margin - - -
EPS - -0.0318 -0.4787
Free Cash Flow - - -1.963
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 8/14/23 8/14/23 3/29/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 0.12 0.58 0.63
Net Cash position 1 - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - - -1.96
ROE (net income / shareholders' equity) - 159% -1,045%
ROA (Net income/ Total Assets) - - -102%
Assets 1 - - 12.79
Book Value Per Share - -0.0300 0.1200
Cash Flow per Share - 0 0
Capex - - -
Capex / Sales - - -
Announcement Date 8/14/23 8/14/23 3/29/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
TELOMIR PHARMACEUTICALS, INC. Stock Telomir Pharmaceuticals, Inc.
0.00% 194M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 695B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 239B
NOVARTIS AG Stock Novartis AG
+6.68% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TELO Stock
  4. Financials Telomir Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW